Monetizing Sano

By BC Staff | Dec 7, 1998 | 8:00 AM GMT

In 1997, Elan Corp. plc placed a $375 million bet on Sano Corp. in an acquisition designed to add late-stage products to ELN's pipeline and strengthen its transdermal drug delivery technology. One of those late-stage products - a smoking cessation patch - now looks unlikely

Read the full 450 word article

How to gain access

Continue reading with a
two-week free trial.